Multiple Assemblies exist for SMTL entry 4cbt
Design, synthesis, and biological evaluation of potent and selective Class IIa HDAC inhibitors as a potential therapy for Huntington's disease; X-RAY DIFFRACTION 3.03 Å

	SMTL ID 4cbt.1 Ligands (1R,2R,3R)-2-[4-(5-fluoranylpyrimidin-2-yl)phenyl]-N-oxidanyl-3-phenyl-cyclopropane-1-carboxamide; ZINC ION Polypeptides HISTONE DEACETYLASE 4 Oligo-state monomer
	SMTL ID 4cbt.2 Ligands (1R,2R,3R)-2-[4-(5-fluoranylpyrimidin-2-yl)phenyl]-N-oxidanyl-3-phenyl-cyclopropane-1-carboxamide; ZINC ION Polypeptides HISTONE DEACETYLASE 4 Oligo-state monomer
	SMTL ID 4cbt.3 Ligands (1R,2R,3R)-2-[4-(5-fluoranylpyrimidin-2-yl)phenyl]-N-oxidanyl-3-phenyl-cyclopropane-1-carboxamide; ZINC ION Polypeptides HISTONE DEACETYLASE 4 Oligo-state monomer